Filing Details
- Accession Number:
- 0001209191-22-018129
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-11 14:34:36
- Reporting Period:
- 2022-03-10
- Accepted Time:
- 2022-03-11 14:34:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651311 | Merus N.v. | MRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1790314 | B. Peter Silverman | C/O Merus N.v. Yalelaan 62 Utrecht P7 3584 CM | Evp, Gc And Head Of Utrecht | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2022-03-10 | 60,000 | $11.16 | 60,000 | No | 4 | M | Direct | |
Common Shares | Disposition | 2022-03-10 | 60,000 | $26.95 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Share Option (right to buy) | Disposition | 2022-03-10 | 60,000 | $0.00 | 60,000 | $11.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,100 | 2029-02-20 | No | 4 | M | Direct |
Footnotes
- Represents the exercise price of the options originally granted on February 20, 2019.
- Amount represents the weighted average price of shares sold, which ranged from $26.50 to $27.36. Details of individual transactions are available upon request.
- Options vest over a four-year period commencing February 20, 2019. 25% vest after one year and in 36 equal monthly installments thereafter.
- Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on February 20, 2019.